Clinical Trial Update: The Effect of Nasal Carbon Dioxide in the Treatment of Moderate to Severe Migraine [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nasal carbon dioxide for moderate to severe migraine was terminated; no efficacy data is reported in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Nasal carbon dioxide (carbon dioxide)

Snippet

Sponsor: Capnia, Inc. | Conditions: Migraine | Phase 2 | Status: TERMINATED